May 15 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.58 8.12 10.76
(+17.9 pct) (-9.7 pct) (+12.4 pct)
Operating 815 mln 1.36 604 mln
(-39.9 pct) (+10.4 pct) (-25.9 pct)
Recurring 1.07 1.34 508 mln
(-20.5 pct) (+12.1 pct) (-52.4 pct)
Net
Net 708 mln 812 mln 340 mln
(-12.7 pct) (+24.2 pct) (-51.9 pct)
EPS 88.85 yen 122.27 yen 42.74 yen
Ann Div 8.00 yen 8.00 yen 8.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 8.00 yen 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T